EP2563350
THERAPEUTIC REGIMEN AND METHOD FOR TREATING OR AMELIORATING VISUAL DISORDERS ASSOCIATED WITH AN ENDOGENOUS RETINOID DEFICIENCY
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
19.4.2011EP published:
14.10.2020EP application number:
11771664.7
EPO information:
European Patent Register
Max expiry date:
18.4.2031
Title:
THERAPEUTIC REGIMEN AND METHOD FOR TREATING OR AMELIORATING VISUAL DISORDERS ASSOCIATED WITH AN ENDOGENOUS RETINOID DEFICIENCY
Timeline
Today
19.4.2011EP application
14.10.2020EP Publication
Owner
Name:
Retinagenix Therapeutics, Inc.Address:
421 Kipling Street, Palo Alto, California 94301, US
Inventor
Name:
STRONG, H., AndrewAddress:
North Vancouver, British Colombia V7R 3S7, CA
Name:
CADDEN, SuzanneAddress:
North Vancouver, British Columbia V7P 2J7, CA
Name:
BOCH, Ronald ErwinAddress:
North Vancouver, British Colombia V7R 3K2, CA
Priority
Number:
407436 PDate:
27.10.2010Country:
US
Number:
325763 PDate:
19.4.2010Country:
US
Number:
447611 PDate:
28.2.2011Country:
US
Classification
Categories:
A61K 31/11, A61K 31/21, A61K 31/222, A61P 27/02, A61K 31/215, A61K 9/00, A61K 47/44